INOTIV INC

Inotiv Inc. provides nonclinical and analytical drug discovery and development services to the pharmaceutical and medical device industries. It operates through two segment Discovery and Safety Assessment (DSA) and Research Models and Services (RMS). The DMS segment manufactured scientific instruments for life sciences research and the related software for use by pharmaceutical companies universities government research centers and medical research institutions under the Company's BASi product line. The RMS segment engages in commercial production and sales of research models diets bedding and bioproducts. The company offers research and discovery services including computational toxicology disease pharmacology DMPK safety pharmacology discovery bioanalysis exploratory surgical models and medical device and cell and molecular biology; non-clinical safety assessment includes general and genetic toxicology regulated bioanalysis biotherapeutics and development and reproductive toxicology; pathology services such as histology digital clinical and medical device pathology; bioanalysis includes nonregulated discovery bioanalysis biotherapeutics and regulated preclinical and clinical bioanalysis; proteomics; and consulting services. The company operates in the United States rest of North America the Pacific Rim Europe and internationally. The company was formerly known as Bioanalytical Systems Inc. and changed its name to Inotiv Inc. in March 2021. Inotiv Inc. was incorporated in 1974 and is headquartered in West Lafayette Indiana.